Is TRBRX or MRK a better dividend investment in 2026?

TRBRX currently yields 2.57% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: MRK offers higher current income.

What is the dividend yield difference between TRBRX and MRK?

TRBRX has a forward dividend yield of 2.57% ($0.33/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 0.68 percentage points.

Home › Compare › TRBRX vs MRK

TRBRX vs MRK: Dividend Comparison 2026

TRBRX yields 2.57% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TRBRX wins by $57.0K in total portfolio value· pulled ahead in Year 3

INVESTMENT

TIME HORIZON10 years

TRBRX

● Live price

2.57%

Share price

$12.73

Annual div

$0.33

5Y div CAGR

42.2%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$87.7K

Annual income

$26,865.10

Full TRBRX calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — TRBRX vs MRK

📍 TRBRX pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TRBRX	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TRBRX + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TRBRX pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRBRX

Annual income on $10K today (after 15% tax)

$218.34/yr

After 10yr DRIP, annual income (after tax)

$22,835.34/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, TRBRX beats the other by $22,027.59/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRBRX + MRK for your $10,000?

TRBRX: 50%MRK: 50%

100% MRK50/50100% TRBRX

Portfolio after 10yr

$59.2K

Annual income

$13,907.70/yr

Blended yield

23.48%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TRBRX

No analyst data

Altman Z

1.4

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRBRX buys

MRK buys

No recent congressional trades found for TRBRX or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTRBRXMRK

Forward yield	2.57%	3.25% ✓
Annual dividend / share	$0.33	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	42.2% ✓	8.2%
Portfolio after 10y	$87.7K ✓	$30.7K
Annual income after 10y	$26,865.10 ✓	$950.29
Total dividends collected	$61.4K ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: TRBRX vs MRK ($10,000, DRIP)

Year	TRBRX Portfolio	TRBRX Income/yr	MRK Portfolio	MRK Income/yr	Gap
1	$11,065	$365.27	$11,192	$351.54	$127.00 → MRK
2	$12,377	$537.15	$12,524	$392.70	$147.00 → MRK
3← crossover	$14,042	$798.48	$14,015	$438.65	+$27.00 → TRBRX
4	$16,229	$1,203.90	$15,682	$489.96	+$547.00 → TRBRX
5	$19,214	$1,849.12	$17,547	$547.23	+$1.7K → TRBRX
6	$23,468	$2,909.46	$19,632	$611.16	+$3.8K → TRBRX
7	$29,834	$4,722.75	$21,963	$682.53	+$7.9K → TRBRX
8	$39,901	$7,978.81	$24,571	$762.18	+$15.3K → TRBRX
9	$56,876	$14,181.72	$27,486	$851.08	+$29.4K → TRBRX
10	$87,722	$26,865.10	$30,745	$950.29	+$57.0K → TRBRX

TRBRX vs MRK: Complete Analysis 2026

TRBRX — Stock

The fund pursues its objective by investing in a diversified portfolio of other T. Rowe Price stock and bond mutual funds that represent various asset classes and sectors. The fund's allocation among T. Rowe Price mutual funds will change over time in relation to its target retirement date. It is designed for an investor who retired at or about the target date and who plans to withdraw the value of the account in the fund gradually after retirement.

Full TRBRX Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this TRBRX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRBRX vs SCHD TRBRX vs JEPI TRBRX vs O TRBRX vs KO TRBRX vs MAIN TRBRX vs JNJ TRBRX vs ABBV TRBRX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.